Preclinical studies of DRP-104 in targeting glutamine metabolism of prostate cancer
Research Grant
Administered By
Pathology
Awarded By
Dracen Pharmaceuticals
Start Date
April 21, 2022
End Date
May 31, 2024
Administered By
Pathology
Awarded By
Dracen Pharmaceuticals
Start Date
April 21, 2022
End Date
May 31, 2024